Filing Details
- Accession Number:
- 0001567619-21-006242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-12 17:45:15
- Reporting Period:
- 2021-03-10
- Accepted Time:
- 2021-03-12 17:45:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444380 | Nevro Corp | NVRO | Surgical & Medical Instruments & Apparatus (3841) | 562568057 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1620611 | Louise Niamh Pellegrini | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-10 | 750 | $64.95 | 39,968 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-10 | 750 | $148.08 | 39,218 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-10 | 750 | $0.00 | 750 | $64.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
65,575 | 2029-07-14 | No | 4 | M | Direct |
Footnotes
- Includes 38,563 restricted stock units.
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- 25% of the shares subject to the option vest on the first anniversary measured from July 15, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.